2017年9月7日に東北医学会、新学術領域「個性」創発脳、日本神経化学会の共催によりエラスムス大学のElgersma教授によるセミナーを開催します。

日時：平成29年9月7日（木）10:0～11:00
会場：東北大学星陵会館2階大会議室

Ype Elgersma教授

エラスムス大学医療センター
ENCORE神経発達障害センター

【演題】
Understanding the mechanisms underlying neurodevelopmental disorders and identifying treatments

【講演要旨】

Intellectual disability (ID) is present in 2% of all children. Recent evidence suggests that in the majority of the cases a genetic mutation is the primary cause of the intellectual disability. Knowledge of the role of mutated gene is an important step in trying to understand the molecular mechanisms leading to ID, and helps us to design therapeutic strategies in which we try to ameliorate the symptoms associated with these disorders.

In this presentation I will in particular focus on our research on Angelman Syndrome. Angelman syndrome (AS) is a severe neurological disorder, affecting 1:20,000. Children with AS present with severe intellectual disability, motor dysfunction and absence of speech. In addition, there is a high comorbidity with epilepsy and behavioral deficits. AS is caused by spontaneous mutations in the UBE3A gene. Currently, there are no effective treatments for this devastating disorder. Therefore, the primary aim of our research is to advance our knowledge of the underlying pathophysiology of AS with the ultimate aim to identify promising approaches for improving therapeutic treatment.

PDFファイルを見る